Regulatory Information
APEX PHARMA MARKETING PTE. LTD.
APEX PHARMA MARKETING PTE. LTD.
Therapeutic
Prescription Only
Formulation Information
CREAM
**DOSAGE AND ADMINISTRATION** For external use only. Apply sparingly onto the affected area 2 to 3 times a day. When a favourable response is obtained, reduce application gradually and eventually discontinue.
TOPICAL
Medical Information
**INDICATIONS** For the relief of inflammatory manifestations of corticosteroid-responsive dermatoses such as in eczema, infantile eczema, atopic dermatitis, dermatitis herpetiformis, contact dermatitis, seborrheic dermatitis, neurodermatitis, some form of psoriasis and intertrigo.
**CONTRAINDICATIONS** Unless under medical supervision, **Uniflex** should not be used for rosacea or on areas around the mouth. **Uniflex** should not be used for acne, viral skin infections e.g. herpes simplex (cold sores) and chicken pox; fungal infections e.g. candidiasis; bacterial infections; in patients with a history of sensitivity to any of its components. Do not use in children under one year of age, including dermatitis and napkin eruptions.
D07AC01
betamethasone
Manufacturer Information
APEX PHARMA MARKETING PTE. LTD.
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD
Active Ingredients
Documents
Package Inserts
Uniflex PI.pdf
Approved: November 25, 2020